Digital Health RX

Why It Matters

The series provides rare, specialized tax and regulatory intelligence that can accelerate funding and growth for digital‑health companies navigating a fragmented compliance landscape.

Key Takeaways

• Withum launches "Digital Health RX" podcast mini‑series.
• Host Luca Panarelli is Withum’s tax partner for digital health.
• Episodes cover business structuring, regulation, fundraising, and exits.
• Targets startups from pre‑revenue to multinational exits.
• Leverages Withum’s sector expertise for actionable insights.

Pulse Analysis

The digital‑health sector is booming, with U.S. venture capital pouring over $30 billion into telemedicine, AI diagnostics, and remote monitoring in the past year alone. Yet rapid growth collides with a patchwork of federal and state regulations, complex tax considerations, and evolving reimbursement models. Companies that fail to align their corporate structures and compliance frameworks risk costly delays, regulatory penalties, or missed financing opportunities. By delivering concise, expert‑driven content, Withum’s new podcast addresses this knowledge gap, helping firms pre‑empt legal hurdles and position themselves for sustainable scaling.

Podcasts have become a trusted learning channel for busy executives, offering on‑demand expertise without the overhead of consulting engagements. Luca Panarelli, a tax partner who co‑leads Withum’s Digital Health practice, brings firsthand experience guiding startups through Series A rounds, IPO preparations, and cross‑border M&A. His ability to translate dense tax code into actionable steps makes the series especially valuable for founders lacking in‑house counsel. Episodes feature guest speakers from leading health‑tech firms, providing real‑world case studies that illustrate best practices in entity selection, data‑privacy compliance, and capital‑structure optimization.

For the broader ecosystem, "Digital Health RX" signals a shift toward more accessible, high‑quality advisory content. As regulatory scrutiny intensifies—exemplified by recent FDA guidance on digital therapeutics—companies that stay informed can secure faster approvals and attract strategic investors. The podcast’s focus on exit strategies also equips founders to maximize valuation when pursuing acquisitions or public listings. In an industry where speed and compliance are competitive differentiators, Withum’s initiative is poised to become a go‑to resource, fostering smarter growth and reducing costly missteps for the next generation of digital‑health innovators.